Adam Gibb, Craig Jones, Adrian Bloor, Samar Kulkarni, Tim Illidge, Kim Linton, and John Radford. 2013. “Brentuximab Vedotin in Refractory CD30+ Lymphomas: A Bridge to Allogeneic Transplantation in Approximately One Quarter of Patients Treated on a Named Patient Programme at a Single UK Center”. Haematologica 98 (4). Pavia, Italy, 611-14. https://doi.org/10.3324/haematol.2012.069393.